| 000 | 00945 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513135443.0 | ||
| 264 | 0 | _c19980413 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0105-4538 | ||
| 024 | 7 |
_a10.1111/j.1398-9995.1998.tb03781.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNolte, H | |
| 245 | 0 | 0 |
_aOptimal maintenance dose immunotherapy based on major allergen content or potency labeling. _h[electronic resource] |
| 260 |
_bAllergy _cJan 1998 |
||
| 300 |
_a99-100 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAllergens _xadministration & dosage |
| 650 | 0 | 4 |
_aAsthma _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypersensitivity, Immediate _xdiagnosis |
| 650 | 0 | 4 |
_aImmunotherapy _xstandards |
| 650 | 0 | 4 |
_aSkin Tests _xmethods |
| 773 | 0 |
_tAllergy _gvol. 53 _gno. 1 _gp. 99-100 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1398-9995.1998.tb03781.x _zAvailable from publisher's website |
| 999 |
_c9459395 _d9459395 |
||